Goldman Sachs: Increases Boston Scientific's target price to $103
ehmhb25
发表于 2024-12-19 09:56:36
1154
0
0
Securities Times Online News: Goldman Sachs has raised its target stock price for Boston Scientific to $103 and maintained a buy rating. Recently, several institutions have also adjusted their target stock prices for Boston Scientific. Citigroup has raised its target stock price from $98 to $107, maintaining a buy rating; Wells Fargo has raised its target stock price from $98 to $100, maintaining its overweight rating.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Morgan Stanley: Increases Broadcom's target price to $233
- Goldman Sachs: Increases Costco target price to $1052
- Morgan Stanley raises IBM target price to $222
- JPMorgan Chase: Upgrades CBRE rating to $163 increase target price
- Pfizer expects revenue of $61 billion to $64 billion in 2025, with an estimated $63.23 billion
- Morgan Stanley: Lowering Western Oil Target Price to $63
- Goldman Sachs: Raise Fox's target price to $57
- Goldman Sachs: Lowering Micron Technology's Target Stock Price to $128
- Citigroup raises Reddit's target price from $120 to $200